Results 1 to 10 of about 2,208 (222)

Cyclic-AMP regulates postnatal development of neural and behavioral responses to NaCl in rats. [PDF]

open access: yesPLoS ONE, 2017
During postnatal development rats demonstrate an age-dependent increase in NaCl chorda tympani (CT) responses and the number of functional apical amiloride-sensitive epithelial Na+ channels (ENaCs) in salt sensing fungiform (FF) taste receptor cells ...
Jie Qian   +12 more
doaj   +5 more sources

Desmopressin use in major cardiac surgery is associated with renal impairment: a retrospective single-center analysis [PDF]

open access: yesBMC Anesthesiology
Background Desmopressin acetate (1-deamino-8-d-arginine vasopressin—DDAVP) is a analogue of the antidiuretic hormone vasopressin. DDAVP is suggested to reduce bleeding after cardiac surgery using cardiopulmonary bypass.
Andreas Koköfer   +5 more
doaj   +2 more sources

Vasopressin Analog [V4Q5]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models. [PDF]

open access: yesWorld J Oncol, 2023
Background: Colorectal cancer (CRC) is a leading cause of cancerassociated mortality worldwide. Despite being an essential component of systemic chemotherapy for advanced CRC, 5-fluorouracil (5-FU) clinical use has severe limitations, such as high ...
Sobol NT   +4 more
europepmc   +3 more sources

Korean guideline of desmopressin for the treatment of nocturia in men [PDF]

open access: yesInvestigative and Clinical Urology, 2022
Purpose: Nocturia is the most bothersome of lower urinary tract symptoms in men. Desmopressin, a synthetic analog of the human hormone vasopressin, has been used for the treatment of nocturia.
Eu Chang Hwang   +9 more
doaj   +1 more source

Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial [PDF]

open access: yesInvestigative and Clinical Urology, 2021
Purpose: To assess the efficacy of desmopressin plus anticholinergic combination therapy as first-line treatment for children with primary monosymptomatic nocturnal enuresis (PMNE) and to analyze this combination's effect on functional bladder capacity ...
Myungsun Shim   +4 more
doaj   +1 more source

Idiopathic partial central diabetes insipidus

open access: yesEinstein (São Paulo), 2023
Diabetes insipidus is a rare disorder characterized by the inability to concentrate urine, which results in hypotonic urine and increased urinary volume.
Larissa Fabre, Viviane Calice da Silva
doaj   +1 more source

Otorhinolaryngological adverse effects of urological drugs

open access: yesInternational Brazilian Journal of Urology, 2021
Purpose: To describe the otorhinolaryngological adverse effects of the main drugs used in urological practice. Materials and Methods: A review of the scientific literature was performed using a combination of specific descriptors (side effect, adverse ...
Nathalia de Paula Doyle Maia   +2 more
doaj   +1 more source

Clotting Factor XIII and desmopressin improve hemostasis in uncontrolled bleeding [PDF]

open access: yesActa Cirúrgica Brasileira, 2015
PURPOSE: To investigate hemostatic effects of supplementary factor XIII and desmopressin (DDAVP) in resuscitation of uncontrolled bleeding.METHODS:Fifty-four rabbits were randomized in nine groups: G1: Sham; G2: FXIII and normotensive resuscitation (NBP);
Paulo Roberto Lima Carreiro   +7 more
doaj   +1 more source

Diagnostic Power of Bilateral Inferior Petrosal Sinus Sampling with Desmopressin in Paediatric Cushing's Disease

open access: yesJCRPE, 2022
INTRODUCTION: The aim of this study was to evaluate the diagnostic accuracy of bilateral inferior petrosal sinus sampling (BIPSS) with desmopressin for pediatric Cushing's disease (CD).
Manuel André Virú-loza   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy